http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I770501-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8bab34457c0c62aadf06ac0280240a61
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-553
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
filingDate 2020-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_104a75602f95389da2b22d9f3b832657
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_901141bc3000220a7071c4f5b720d72f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6070ba1c45d515dba84a83d15a24cc9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd2947df8dfabbe625925a07fd7a7422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1295b545e8d58b12ea27b271771e4510
publicationDate 2022-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TW-I770501-B
titleOfInvention Novel indole-2-carboxamides active against the hepatitis b virus (hbv)
abstract The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.
priorityDate 2019-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018005883-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201925199-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018011163-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420236130
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID594832

Total number of triples: 34.